Blog - Page 1387 of 5764

ThursdayJun 17, 2021 10:52 am

Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Announces First-Ever Trial to Treat COVID-19 Frontline Clinicians, Unveils EMBARK Model

The study will examine treating symptoms of depression, anxiety, burnout and post-traumatic stress EMBARK is groundbreaking psychotherapy model that integrates leading clinical approaches to promote supportive healing with psychedelic medicine Cybin considers it an honor, duty to support healing processes of doctors, nurses and healthcare professionals, says CEO In the first-ever study of its kind, Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, has announced that it is co-sponsoring a study focused on treating frontline clinicians experiencing COVID-related distress (https://ibn.fm/NvMAo). In addition to co-sponsoring the study, Cybin also announced the development of EMBARK, a groundbreaking…

ThursdayJun 17, 2021 10:51 am

QualityStocksNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Featured in Latest Episode of Bell2Bell Podcast

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a life sciences technology accelerator, was featured in the Bell2Bell Podcast, a part of InvestorBrandNetwork’s (“IBN”) sustained effort to provide specialized content distribution via widespread syndication channels. XPhyto Therapeutics’ CEO and Director Hugh Rogers joined the latest episode to offer an operational update and discuss the company’s achievements and future plans. XPhyto Therapeutics recently secured European approval and launched an effective 25-minute polymerase chain reaction (“PCR”) test for COVID-19 (“Covid-ID Lab”), with an initial focus on the German market and several other initiatives underway. “This is an exciting time for the company.…

ThursdayJun 17, 2021 10:39 am

FingerMotion Inc. (FNGR) On Upward Trajectory as FYE Report Shows Record Growth, Dawning Big Data Revenues

China-focused communications technology company FingerMotion is riding a wave of optimism following FYE 2020 reporting that showed revenues have nearly reached $17 million and gross profits rose 71 percent The company also saw the initial revenues from its new venture into big data, which it expects to become a primary driver of its business profile as it draws on mobile users’ information to power its predictive services FingerMotion’s Sapientus platform for predictive services was a huge draw in establishing a landmark agreement with Pacific Life Re-insurance for Pacific Life’s insurtech solutions in China Sapientus’ predictive database has the potential to…

ThursdayJun 17, 2021 10:39 am

QualityStocksNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) CEO Featured Guest in Latest Stock2Me Podcast

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a pharmaceutical company focused on developing clinical-stage compounds for diseases with unmet medical needs, announced that chairman and CEO Greg McKee was interviewed on the most recent episode of the Stock2Me Podcast. The podcast features a fascinating array of companies and individuals that are actively revolutionizing business practices within their respective markets. In the interview, McKee talked about the objective of TRYP, which is fundamentally to help patients, as well as identifying and bringing new therapies to patients. McKee also discussed the need for innovation in the psychedelics space and Tryp’s upcoming human clinical…

ThursdayJun 17, 2021 10:33 am

Healthtech Solutions Inc. (HLTT) Initiates Incubator Model to Develop Powerful Biotech and Medtech Portfolio

Providing invaluable support to promising startups sets HLTT apart as early-stage companies work to break with tradition, launch their own products Playing a strategic role during critical phases of company life-cycles is a key approach that Healthtech is confident will breed increased chances of success VarianBio joins MediScan, RevHeart as trio of innovative healthcare technology companies in HLTT portfolio A new trend is emerging in the world of drug development — a trend that Healthtech Solutions (OTC: HLTT) is intent on leveraging as it focuses on developing a strong portfolio model in biotech and medtech. That commitment to reinventing the incubator model…

ThursdayJun 17, 2021 10:28 am

QualityStocksNewsBreaks — VistaGen Therapeutics Inc. (NASDAQ: VTGN) Announces Plans to Join Russell 2000 Index

VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company committed to developing and commercializing a new generation of medicines with the potential to go beyond the current standard of care for anxiety, depression and other central nervous system (“CNS”) disorders, will be added to the Russell 2000(R) Index effective Monday, June 28, 2021. The company will be added to the index at the conclusion of the 2021 Russell Indexes annual reconstitution. Investment managers and institutional investors often use the Russell U.S. Indexes, which are part of global index provider FTSE Russell, as a basis for index funds and as benchmarks for active…

ThursdayJun 17, 2021 9:57 am

BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) to Launch TRACE Alkaline and Mineralized Water in U.S. Via New Distribution Partner

Alkaline water is emerging segment in $217.7 billion global bottled water market BevCanna has partnered with leading U.S. inventory and fulfillment technology platform provider for the launch of TRACE alkaline and mineralized waters in the U.S. TRACE is already sold online and at over 3,000 retail locations in Canada, distribution points that will be further increased following separate agreement with top eastern Canada distributor While the COVID-19 pandemic was keeping people on lockdown, the logistics industry was thriving, as consumers became increasingly familiar with shopping from home. At the same time, the premium bottled water industry continues to gain traction…

ThursdayJun 17, 2021 9:00 am

Brain Scientific Inc. (BRSF) Poised to Contribute to Mental Health Research; Provides Technology to Map Brain Response to Psychedelic Treatment

BRSF has partnered with Ehave to conduct research connected to biochemical biomarkers concerning psychedelic drug administration Psychedelic drugs show promise in treating neurological disorders, including chronic pain, depression, and PTSD, but more research is needed BRSF's E-Tattoo is poised to bring benefits of biomarkers to neurological and psychiatric research; allows monitoring of patient's brain activity in a non-intrusive way Brain Scientific (OTCQB: BRSF) has partnered with Ehave, Inc., a provider of digital therapeutics for the psychedelic and mental health sectors, to use data and AI algorithms to statistically correlate biomarkers for the identification of psychedelic drug administration as a treatment…

ThursdayJun 17, 2021 9:00 am

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Commences Production of 1 Gram FSO Vape Cartridges for Canadian Retail Market

Pure Extracts working on innovative, larger capacity cartridge for vape products, destined for Canadian retail market Cartridges to be produced by global manufacturer, will be filled with selection of Pure Extracts’ 30+ proprietary cannabis FSO formulations Move towards larger cartridges follows careful assessment of underlying consumer trends by the Company, finding demand for higher capacity vape cartridges to be particularly strong within provincial markets Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company focused on the cannabis, hemp, functional mushrooms and rapidly emerging psychedelic sector, announced that its wholly owned subsidiary, Pure Extracts Manufacturing Corp., has…

WednesdayJun 16, 2021 1:01 pm

QualityStocksNewsBreaks – Why American Cannabis Partners Is ‘One to Watch’

American Cannabis Partners (“ACP”) is a multistate cannabis company with a retail license and 560,000 square feet of licensed canopy space for cultivation. ACP’s strategy is to capture opportunities in real estate and licensing in states that have recently passed cannabis legalization legislation, thereby equipping the company to capitalize on federal interstate commerce opportunities. As a company that is focused on complementary business segments — real estate, acquisition and development of proprietary assets and ongoing cultivation operations, ACP is targeting expansion. A recent article reads, “American Cannabis Partners is pursuing additional growth in the cannabis sector through multiple planned initiatives.…

Site Search

Company Search